679 related articles for article (PubMed ID: 26880011)
1. Utility of 18F-fluorodeoxy glucose and 18F-sodium fluoride positron emission tomography/computed tomography in the diagnosis of medication-related osteonecrosis of the jaw: A preclinical study in a rat model.
Kim Y; Lee HY; Yoon HJ; Kim BS
J Craniomaxillofac Surg; 2016 Apr; 44(4):357-63. PubMed ID: 26880011
[TBL] [Abstract][Full Text] [Related]
2. Fluorodeoxyglucose positron emission tomography with computed tomography detects greater metabolic changes that are not represented by plain radiography for patients with osteonecrosis of the jaw.
Fleisher KE; Raad RA; Rakheja R; Gupta V; Chan KC; Friedman KP; Mourtzikos KA; Janal M; Glickman RS
J Oral Maxillofac Surg; 2014 Oct; 72(10):1957-65. PubMed ID: 25053572
[TBL] [Abstract][Full Text] [Related]
3. Mitigating jaw osteonecrosis: bioactive glass and pericardial membrane combination in a rat model.
Pellicano AA; Benites BM; Paschoa AFN; Oliveira LC; Campos ACP; Martins DO; Real CC; de Paula Faria D; Fonseca FP; Martinez RRC; Pagano RL; Fregnani ER
Front Oncol; 2024; 14():1348118. PubMed ID: 38800378
[TBL] [Abstract][Full Text] [Related]
4. Hybrid PET- and MR-driven attenuation correction for enhanced
Karakatsanis NA; Abgral R; Trivieri MG; Dweck MR; Robson PM; Calcagno C; Boeykens G; Senders ML; Mulder WJM; Tsoumpas C; Fayad ZA
J Nucl Cardiol; 2020 Aug; 27(4):1126-1141. PubMed ID: 31667675
[TBL] [Abstract][Full Text] [Related]
5. Treatment response evaluation with
Sachpekidis C; Hillengass J; Goldschmidt H; Wagner B; Haberkorn U; Kopka K; Dimitrakopoulou-Strauss A
Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):50-62. PubMed ID: 27573638
[TBL] [Abstract][Full Text] [Related]
6. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.
Minamimoto R; Loening A; Jamali M; Barkhodari A; Mosci C; Jackson T; Obara P; Taviani V; Gambhir SS; Vasanawala S; Iagaru A
J Nucl Med; 2015 Dec; 56(12):1862-8. PubMed ID: 26405167
[TBL] [Abstract][Full Text] [Related]
7. 18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT.
Piccardo A; Puntoni M; Morbelli S; Massollo M; Bongioanni F; Paparo F; Altrinetti V; Gonella R; Gennari A; Iacozzi M; Sambuceti G; DeCensi A
Nuklearmedizin; 2015; 54(4):163-72. PubMed ID: 26165806
[TBL] [Abstract][Full Text] [Related]
8. Detection of osseous metastasis by 18F-NaF/18F-FDG PET/CT versus CT alone.
Sampath SC; Sampath SC; Mosci C; Lutz AM; Willmann JK; Mittra ES; Gambhir SS; Iagaru A
Clin Nucl Med; 2015 Mar; 40(3):e173-7. PubMed ID: 25140557
[TBL] [Abstract][Full Text] [Related]
9. A Comparison of 18 F-FDG PET/CT and 68 Ga-PSMA PET/CT in Detecting Osteonecrosis of the Jaw in a Patient With Prostate Cancer.
Öztürk AE; Şahin R; Ergül N; Çermik TF; Arslan E
Clin Nucl Med; 2024 Feb; 49(2):e68-e69. PubMed ID: 38170920
[TBL] [Abstract][Full Text] [Related]
10. Prospective comparison of combined 18F-FDG and 18F-NaF PET/CT vs. 18F-FDG PET/CT imaging for detection of malignancy.
Lin FI; Rao JE; Mittra ES; Nallapareddy K; Chengapa A; Dick DW; Gambhir SS; Iagaru A
Eur J Nucl Med Mol Imaging; 2012 Feb; 39(2):262-70. PubMed ID: 22065013
[TBL] [Abstract][Full Text] [Related]
11. Effects of metformin on the prevention of bisphosphonate-related osteonecrosis of the jaw-like lesions in rats.
Nakagawa T; Tsuka S; Aonuma F; Nodai T; Munemasa T; Tamura A; Mukaibo T; Kondo Y; Masaki C; Hosokawa R
J Prosthodont Res; 2021 Jun; 65(2):219-224. PubMed ID: 32938854
[TBL] [Abstract][Full Text] [Related]
12. Osteonecrosis of the jaws (ONJ) in mice after extraction of teeth with periradicular disease.
Soundia A; Hadaya D; Esfandi N; de Molon RS; Bezouglaia O; Dry SM; Pirih FQ; Aghaloo T; Tetradis S
Bone; 2016 Sep; 90():133-41. PubMed ID: 27327410
[TBL] [Abstract][Full Text] [Related]
13. [Superiority of 18F-FNa PET/CT for Detecting Bone Metastases in Comparison with Other Diagnostic Imaging Modalities].
Lapa P; Saraiva T; Silva R; Marques M; Costa G; Lima JP
Acta Med Port; 2017 Jan; 30(1):53-60. PubMed ID: 28501038
[TBL] [Abstract][Full Text] [Related]
14. Incremental Value of Cocktail 18F-FDG and 18F-NaF PET/CT Over 18F-FDG PET/CT Alone for Characterization of Skeletal Metastases in Breast Cancer.
Roop MJ; Singh B; Singh H; Watts A; Kohli PS; Mittal BR; Singh G
Clin Nucl Med; 2017 May; 42(5):335-340. PubMed ID: 28263210
[TBL] [Abstract][Full Text] [Related]
15. 18F-Deoxyglucose (18F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT) Monitoring of Dynamic Growth Characteristics of Walker-256 Tumor Models in 3 Different Locations in Rats.
Li P; Liu Q; Wang X; Huang G; Song S
Med Sci Monit; 2019 Jan; 25():558-564. PubMed ID: 30659557
[TBL] [Abstract][Full Text] [Related]
16. Different lesions revealed by 18F-FDG PET/CT and 18F-NaF PET/CT in patients with multiple myeloma.
Xu F; Liu F; Pastakia B
Clin Nucl Med; 2014 Sep; 39(9):e407-9. PubMed ID: 24217536
[TBL] [Abstract][Full Text] [Related]
17. Semiquantitative Analysis of the Biodistribution of the Combined ¹⁸F-NaF and ¹⁸F-FDG Administration for PET/CT Imaging.
Minamimoto R; Mosci C; Jamali M; Barkhodari A; Habte F; Jackson T; Mittra E; Gambhir SS; Iagaru A
J Nucl Med; 2015 May; 56(5):688-94. PubMed ID: 25840978
[TBL] [Abstract][Full Text] [Related]
18. Combined 18F-NaF and 18F-FDG PET/CT in the Evaluation of Sarcoma Patients.
Jackson T; Mosci C; von Eyben R; Mittra E; Ganjoo K; Biswal S; Gambhir SS; Iagaru A
Clin Nucl Med; 2015 Sep; 40(9):720-4. PubMed ID: 26053718
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Bone Lesions in Myeloma Before and During Anticancer Therapy Using
Nakuz TS; Millinger FP; El-Rabadi K; Weber M; Pichler V; Wadsak W; Mitterhauser M; Haug A; Hacker M; Karanikas G; Pietschmann P; Agis H
Anticancer Res; 2019 Apr; 39(4):1943-1952. PubMed ID: 30952737
[TBL] [Abstract][Full Text] [Related]
20. Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients.
Sonis ST; Watkins BA; Lyng GD; Lerman MA; Anderson KC
Oral Oncol; 2009 Feb; 45(2):164-72. PubMed ID: 18715819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
